Centauri Gets Extra $5.1M from CARB-X for ABX-01 Clinical Trials
29 Jul 2025 //
BUSINESSWIRE
Debra Appointed as Centauri Therapeutics` Chief Medical Officer
08 Jul 2025 //
CONTRACTPHARMA
Centauri Selects First Clinical Candidate For Gram-Negative Infections
04 Mar 2025 //
BUSINESSWIRE
Centauri Therapeutics Awarded PACE Grant for Anti-infectives
26 Nov 2024 //
CONTRACTPHARMA